Medpace Holdings Revenue 2014-2023 | MEDP

Medpace Holdings annual/quarterly revenue history and growth rate from 2014 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Medpace Holdings revenue for the quarter ending December 31, 2023 was $0.498B, a 26.47% increase year-over-year.
  • Medpace Holdings revenue for the twelve months ending December 31, 2023 was $1.886B, a 29.17% increase year-over-year.
  • Medpace Holdings annual revenue for 2023 was $1.886B, a 29.17% increase from 2022.
  • Medpace Holdings annual revenue for 2022 was $1.46B, a 27.8% increase from 2021.
  • Medpace Holdings annual revenue for 2021 was $1.142B, a 23.38% increase from 2020.
Medpace Holdings Annual Revenue
(Millions of US $)
2023 $1,886
2022 $1,460
2021 $1,142
2020 $926
2019 $861
2018 $705
2017 $436
2016 $422
2015 $359
2014 $326
2013 $273
Medpace Holdings Quarterly Revenue
(Millions of US $)
2023-12-31 $498
2023-09-30 $492
2023-06-30 $461
2023-03-31 $434
2022-12-31 $394
2022-09-30 $384
2022-06-30 $351
2022-03-31 $331
2021-12-31 $309
2021-09-30 $296
2021-06-30 $278
2021-03-31 $260
2020-12-31 $260
2020-09-30 $230
2020-06-30 $205
2020-03-31 $231
2019-12-31 $230
2019-09-30 $216
2019-06-30 $214
2019-03-31 $201
2018-12-31 $192
2018-09-30 $179
2018-06-30 $170
2018-03-31 $163
2017-12-31 $113
2017-09-30 $111
2017-06-30 $106
2017-03-31 $107
2016-12-31 $108
2016-09-30 $108
2016-06-30 $106
2016-03-31 $100
2015-12-31
2015-09-30 $92
2014-12-31
2013-12-31
Sector Industry Market Cap Revenue
Medical Medical Services $12.238B $1.886B
Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $115.766B 15.02
Cencora (COR) United States $46.679B 18.63
ICON (ICLR) Ireland $25.244B 24.90
DiDi Global (DIDIY) China $23.367B 0.00
Avantor (AVTR) United States $16.930B 23.33
CochLear (CHEOY) $13.697B 0.00
Viatris (VTRS) United States $13.592B 3.88
Revvity (RVTY) United States $12.784B 22.26
Charles River Laboratories (CRL) United States $12.432B 22.66
EUROFINS SCIENT (ERFSF) Luxembourg $12.209B 0.00
Natera (NTRA) United States $11.408B 0.00
Solventum (SOLV) $10.825B 0.00
Amplifon S.p.A (AMFPF) Italy $7.290B 37.01
HealthEquity (HQY) United States $6.851B 51.19
Bausch + Lomb (BLCO) Canada $4.998B 19.24
Doximity (DOCS) United States $4.826B 35.93
Organon (OGN) United States $4.461B 4.32
Surgery Partners (SGRY) United States $3.334B 30.98
Progyny (PGNY) United States $3.300B 55.16
Sotera Health (SHC) United States $3.193B 15.67
Life Times (LTH) United States $2.817B 31.13
GoodRx Holdings (GDRX) United States $2.698B 136.60
Premier (PINC) United States $2.527B 9.25
Teladoc Health (TDOC) United States $2.406B 0.00
AMN Healthcare Services Inc (AMN) United States $2.146B 6.94
Agilon Health (AGL) United States $2.027B 0.00
BrightSpring Health Services (BTSG) United States $1.720B 0.00
NovoCure (NVCR) Jersey $1.453B 0.00
Establishment Labs Holdings (ESTA) $1.381B 0.00
Agiliti (AGTI) United States $1.366B 22.33
Alignment Healthcare (ALHC) United States $0.888B 0.00
Pediatrix Medical (MD) United States $0.776B 8.03
Embecta (EMBC) United States $0.590B 3.90
Auna S.A (AUNA) Luxembourg $0.569B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.536B 0.00
InnovAge Holding (INNV) United States $0.531B 0.00
Enhabit (EHAB) United States $0.522B 47.27
MultiPlan (MPLN) United States $0.507B 0.00
Beauty Health (SKIN) United States $0.452B 0.00
CareDx (CDNA) United States $0.442B 0.00
LifeMD (LFMD) United States $0.390B 0.00
Sonida Senior Living (SNDA) United States $0.370B 0.00
DocGo (DCGO) United States $0.340B 54.33
ModivCare (MODV) United States $0.319B 4.23
Sera Prognostics (SERA) United States $0.313B 0.00
Sharecare (SHCR) United States $0.266B 0.00
Ascend Wellness Holdings (AAWH) United States $0.252B 0.00
GeneDx Holdings (WGS) United States $0.251B 0.00
Biodesix (BDSX) United States $0.119B 0.00
So-Young (SY) China $0.116B 39.00
Oncology Institute (TOI) United States $0.095B 0.00
Pono Capital Two (PTWO) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.057B 0.00
NeueHealth (NEUE) United States $0.050B 0.00
SeaStar Medical Holding (ICU) United States $0.040B 0.00
Co-Diagnostics (CODX) United States $0.038B 0.00
Nutex Health (NUTX) United States $0.033B 0.00
Singular Genomics Systems (OMIC) United States $0.032B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.031B 0.00
OncoCyte (OCX) United States $0.022B 0.00
DermTech (DMTK) United States $0.022B 0.00
Aesthetic Medical Hldngs Group (AIH) China $0.014B 0.00
BIMI Medical (BIMI) United States $0.012B 0.00
BioNexus Gene Lab (BGLC) $0.012B 0.00
TRxADE HEALTH (MEDS) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.009B 0.00
OpGen (OPGN) United States $0.007B 0.00
XWELL (XWEL) United States $0.006B 0.00
Assure Holdings (IONM) United States $0.005B 0.00
NewGenIvf Group (NIVF) Singapore $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
ISpecimen (ISPC) United States $0.002B 0.00